Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 949,828 | 941,293 | 858,435 | 870,106 | 784,535 |
| Cost of Goods | 131,914 | 135,740 | 95,092 | 122,289 | 111,255 |
| Gross Profit | 817,914 | 805,553 | 763,343 | 747,817 | 673,280 |
| Operating Expenses | 719,495 | 536,333 | 486,627 | 620,384 | 467,886 |
| Operating Income | 99,333 | 269,960 | 276,808 | 127,722 | 205,649 |
| Interest Expense | 14,548 | 14,837 | 14,868 | 18,744 | 18,686 |
| Other Income | -14,119 | 72,015 | 58,225 | -76,481 | -50,452 |
| Pre-tax Income | 70,666 | 327,138 | 320,165 | 32,497 | 136,511 |
| Income Tax | 13,148 | 59,711 | 51,534 | -1,492,599 | 8,055 |
| Net Income Continuous | 57,518 | 267,427 | 268,631 | 1,525,096 | 128,456 |
| Minority Interests | N/A | N/A | N/A | -25,431 | -290 |
| Net Income | $57,518 | $267,427 | $268,631 | $1,550,527 | $128,746 |
| EPS Basic Total Ops | 0.22 | 1.04 | 1.05 | 6.08 | 0.51 |
| EPS Basic Continuous Ops | 0.22 | 1.04 | 1.05 | 5.99 | 0.50 |
| EPS Diluted Total Ops | 0.22 | 1.03 | 1.03 | 5.98 | 0.50 |
| EPS Diluted Continuous Ops | 0.22 | 1.03 | 1.03 | 5.88 | 0.49 |
| EBITDA(a) | $125,180 | $297,658 | $303,948 | $146,548 | $224,841 |